Treatment of neoplastic pericardial effusions;Trattamento dei versamenti pericardici neoplastici

Recenti Progressi in Medicina

Volumn 97, Issue 4, 2006, Pages 206-210

  Martinoni, Alessandro ^a,b  

^a UTIC   (Italy)

^b NONE   (United States)

Author keywords

Bleomycin; Cisplatin; Doxycycline; Intracavitary chemotherapy; Neoplasms; Pericardial effusion; Tetracycline; Thiotepa

Indexed keywords

BLEOMYCIN; CISPLATIN; CYTOSTATIC AGENT; SCLEROSING AGENT; TETRACYCLINE DERIVATIVE; THIOTEPA;

CANCER RECURRENCE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; HUMAN; NEOPLASM; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; THORAX PAIN;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; HEART NEOPLASMS; HUMANS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIUM; TETRACYCLINES; THIOTEPA; TREATMENT OUTCOME;

EID: 33646522229     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Wilkes JD, Fidias P, Vaitkus L, et al. Malignancy-related pericardial effusion. 127 Cases from the Roswell Park Cancer Institute. Cancer 1995; 76: 1377-87.
2. Thurber DL, Edwards JE, Achor RWP. Secondary malignant tumors of the pericardium. Circulation 1962; 26: 228-41.
3. Bisel HF, Wrobleski F, LaDue JS. Incidence and clinical manifestations of cardiac metastases. JAMA. 1953; 153: 712-5.
4. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997; 64: 1422-8.
5. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Management of pericardial effusions. Heart 2001; 86: 235-40.
6. Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary. The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2004; 25: 587-610.
7. Susini G, Pepi M, Fiorentini C, et al. Percutaneous pericardiocentesis versus subxyphoid pericardiotomy in cardiac tamponade due to postoperative pericardial effusion. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7: 178-83.
8. Soler-Soler J, Merce J, Sagrista-Sauleda J. Should pericardiocentesis be performed routinely in patients who have a large pericardial effusion without tamponade? Am J Med 1998; 105: 106-9.
9. Tsang TS, Seward JB, Barnes ME. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 2000; 75: 248-53.
10. Tsang TS, Freeman WK, Sinak LJ et al. Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc 1998; 73: 647-52.
11. Fagan SM, Chan KL. Pericardiocentesis. Blind no more! Chest 1999; 116: 275-6.
12. DeCamp MM, Mentzer SJ, Swanson SJ, et al. Malignant effusive disease of the pleura and pericardium. Chest 1997; 112: 291S-5S.
13. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994; 272: 59-64.
14. Sheperd FA. Malignant pericardial effusion. Curr Opin Oncology 1997; 9: 170-4.
15. Maher EA, Sheperd FA, Todd TJR. Pericardial sclerosis as the primary management of malignant effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996; 112: 637-43.
16. Liu G, Crump M, Goss PE, et al. Prospective comparison of the sclerosis agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996; 14: 3141-7.
17. Sheperd FA, Morgan C, Evans WK et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987; 60: 1161-6.
18. Yano T, Yokoyama H, Inoue T, et al. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994; 51: 507-9.
19. Cormican MC, Nyman CR. Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. Br Heart J 1990; 63: 61-2.
20. Tomkowski W, Wi'sniewska J, Szturmowicz M, Kuca P, Burakowski J, Kober J, Fija_kowska A. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 2004; 12: 53-7.
21. Maisch B, A, Ristić D, Pankuweit S, Neubauer A. Moll R. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. European Heart Journal 2002; 23: 1625-31.
22. Tondini M, Rocco G, Corbellini D. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Archives for Chest disease 1995; 50: 86-8.
23. Colleoni M, Cipolla C, Martinoni A, Goldhirsh A, et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol 1998; 16: 2371-6.
24. Martinoni A, Cipolla CM, Cardinale D, et al. Longterm results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with Thiotepa.Chest 2004; 126: 1412-6.
25. Bishiniotis TS, Antoniadou S, Katseas G. Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of Triethylenthiophosphoramide (Thiotepa). Am J Cardiol 2000; 86: 362-4.
26. Koontz WW, Prout GR, Smith W, et al. The use of intravescical thiotepa in the management for non-invasive carcinoma of the bladder. J Urol 1981; 125-307-12.
27. Garcia Moore ML, Savaraj N, Feun LG, et al. Successful therapy of peritoneal mesothelioma with intraperitoneal chemotherapy alone. A case report. Am J Clin Oncol 1992; 15: 528-30.